Monthly Archives: March 2025

PAN-AMPK Activator ATX-304 Improves Glucose Homeostasis and Microvascular Perfusion

Introduction to Type 2 Diabetes and the Emergence of ATX-304 The United States is currently grappling with a severe Type 2 Diabetes (T2D) epidemic, a situation deeply intertwined with various lifestyle and demographic factors. This chronic condition, characterized primarily by insulin resistance and a progressive decline in insulin production, has become a major public health […]

UB-312 Parkinson’s Peptide Produces Antibodies Targeting α-synuclein Lewy bodies

UB-312 synthetic peptide induces antibodies against a-synuclein as a treatment for Parkinson’s disease. Alpha-synuclein (αSyn) is an essential neuronal protein in the nerve terminal that inhibits neurotransmitter release when over-expressed.[8] In general terms, the αSyn preserves the normal function of synapses, which is how information is transmitted between neurons.[8] However, dysfunction of the αSyn protein causes the […]

The Role of Senescent Cells in Alzheimer’s Disease

The Role of Senescent cells in Alzheimer’s Disease The aging process is strongly associated with developing diseases, such as cardiovascular conditions, hypertension, cancer, diabetes mellitus, osteoporosis, and neurodegenerative diseases, among others. [10,12] Alzheimer’s disease (AD) is no exception since aging is a risk factor for late-onset AD (more than 95% of AD cases). [14,15] Another factor highly associated with […]

What is JNJ-2113 and How Does it Work?

About JNJ-77242113 (JNJ-2113) JNJ-2113 stands out as the first oral peptide specifically designed to inhibit the IL-23 receptor. This means it blocks the activity of the IL-23 receptor, which is a protein involved in the immune system’s inflammatory processes. Interleukin-23 plays a significant role in the development and progression of plaque psoriasis, a chronic skin […]

miRNA Researched for Parkinson’s Disease: Neuroprotection Blocks Neuron Death

Programmed cell death, better known as apoptosis, is crucial in eliminating abnormal or unwanted cells in the body.[2] In recent years, the complex pathways regulating apoptosis have been well-studied as potential therapy targets.[2,10] Parkinson’s disease (PD) is no exception since the leading cause of this disorder is the death of dopamine-producing neurons in the brain (see Fig.1).[1-4] PD […]

What is Retatrutide and How Does it Work?

What is Retatrutide? Retatrutide is a notable triple-agonist peptide, which means it targets three different hormone receptors: GLP-1 (glucagon-like peptide-1), GIP (gastric inhibitory polypeptide), and glucagon. These hormones play vital roles in regulating blood sugar, appetite, and energy expenditure, making Retatrutide a promising candidate for treating obesity and potentially type 2 diabetes mellitus.   The […]

Cellular Senescence: What is it?

What is Cellular Senescence?  Cellular senescence is a state in which cells permanently stop dividing while remaining metabolically active, typically triggered by DNA damage or other cellular stressors. First described by Leonard Hayflick in studies of human fetal fibroblasts, senescence distinguishes non-transformed cells from malignant cells, which can replicate indefinitely. Unlike quiescent cells, which can […]

Part 2: “Cellular Senescence: What Can Be Done About It?”

Brief overview/Summary Cellular senescence is a natural process with both protective and harmful effects. Throughout life, senescence helps prevent tumor formation and mitigate tissue damage. However, as individuals age, senescent cells accumulate in tissues, potentially contributing to various age-related diseases. Recent research has uncovered the molecular mechanisms that support the survival of senescent cells and […]